1.18
price up icon30.39%   0.275
after-market Dopo l'orario di chiusura: 1.34 0.16 +13.56%
loading

Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.75%
0.9669
1.0259 1.0242 1.67 1.3701
Interest Income/Expense
29.17%
0.00719
0.0101 0.000279 0.00195 0.00386
Operating Income/Loss
5.75%
-0.9669
-1.0259 -1.0242 -1.67 -1.3701
Income/Loss From Continuing Operations Before Tax
5.90%
-0.9713
-1.0323 -1.0188 -1.6684 -1.3677
Income/Loss From Continuing Operations After Tax
5.90%
-0.9713
-1.0323 -1.0188 -1.6684 -1.3677
Net Income/Loss
5.90%
-0.9713
-1.0323 -1.0188 -1.6684 -1.3677
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,902%
2.2493
0.1124 2.0749 1.666 16.65
Diluted Average Shares
1,902%
2.2493
0.1124 2.0749 1.666 -0.000477
Basic Earnings Per Share
4.88%
-0.43
-0.41 -0.49 -1.00 -0.08
Diluted Earnings Per Share
4.88%
-0.43
-0.41 -0.49 -1.00 -0.82
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):